Furthermore, we have confirmed that the role of HYP in mediating HCC-SR cell sensitivity to sorafenib is dependent on the USP18-NCOA4 signaling axis (Fig. 6K and Supplementary Fig. S7A–D). This evidence concerns the gene USP18 and hepatocellular carcinoma.